AI Verdict
RGEN has stronger fundamentals based on our AI analysis.
RGPX vs RGEN Fundamental Comparison
| Metric | RGPX | RGEN |
|---|---|---|
| Revenue | $1,775.0 | $738.3M |
| Net Income | $-1.5M | $48.9M |
| Net Margin | -83,244.8% | 6.6% |
| ROE | N/A | 2.3% |
| ROA | -239.2% | 1.7% |
| Current Ratio | 0.01x | 8.37x |
| Debt/Equity | N/A | 0.26x |
| EPS | N/A | $0.86 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RGPX vs RGEN: Frequently Asked Questions
Is RGPX or RGEN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RGEN has stronger fundamentals. RGPX is rated STRONG SELL (98% confidence) while RGEN is rated HOLD (62% confidence). This is not investment advice.
How does RGPX compare to RGEN fundamentally?
REGENEREX PHARMA, INC. has ROE of N/A vs REPLIGEN CORP's 2.3%. Net margins are -83,244.8% vs 6.6% respectively.
Which stock pays higher dividends, RGPX or RGEN?
RGPX has a dividend yield of N/A or no dividend while RGEN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RGPX or RGEN for long term?
For long-term investing, consider that RGPX has STRONG SELL rating with 98% confidence, while RGEN has HOLD rating with 62% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RGPX vs RGEN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RGPX vs RGEN, the AI consensus favors RGEN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.